Healthcare Services (Exemption for Influenza Vaccination at Approved Retail Pharmacies) Order 2024

This Order is the Healthcare Services (Exemption for Influenza Vaccination at Approved Retail Pharmacies) Order 2024 and comes into operation on 1 October 2024.

In this Order —“approved pharmacist” and “approved retail pharmacy” have the meanings given by Part 2 of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016);“holder of a pharmacy licence” means a person who holds a pharmacy licence in respect of an approved retail pharmacy;“pharmacy licence” has the meaning given by regulation 2(1) of the Health Products (Therapeutic Products) Regulations 2016;“sandbox trial” means a trial conducted by the Ministry of Health under a set of terms and conditions issued by that Ministry to a holder of a pharmacy licence to test the feasibility and safety of the administration of influenza vaccines by approved pharmacists.

“approved pharmacist” and “approved retail pharmacy” have the meanings given by Part 2 of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016);

“holder of a pharmacy licence” means a person who holds a pharmacy licence in respect of an approved retail pharmacy;

“pharmacy licence” has the meaning given by regulation 2(1) of the Health Products (Therapeutic Products) Regulations 2016;

“sandbox trial” means a trial conducted by the Ministry of Health under a set of terms and conditions issued by that Ministry to a holder of a pharmacy licence to test the feasibility and safety of the administration of influenza vaccines by approved pharmacists.

This paragraph applies where an influenza vaccine is administered at an approved retail pharmacy under a sandbox trial —

by an approved pharmacist who is employed by the holder of the pharmacy licence issued in respect of the approved retail pharmacy; and

in accordance with the conditions specified in the third column of item 4 of Part 1 of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016.

Section 8 of the Act does not apply to a holder of a pharmacy licence issued in respect of an approved retail pharmacy in relation to the administration of an influenza vaccine at the approved retail pharmacy.

Section 31(1) of the Act does not apply to —

a holder of a pharmacy licence who advertises, or causes to be advertised, any information relating to the administration of an influenza vaccine at the approved retail pharmacy to which the pharmacy licence relates; and

a person who, acting on the authority of a holder of a pharmacy licence, advertises or causes to be advertised, any information relating to the administration of an influenza vaccine at the approved retail pharmacy to which the pharmacy licence relates.

This paragraph applies where an influenza vaccine is administered at an approved retail pharmacy under a sandbox trial —

by an approved pharmacist who is employed by the holder of the pharmacy licence issued in respect of the approved retail pharmacy; and

in accordance with the conditions specified in the third column of item 4 of Part 1 of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016.

Section 8 of the Act does not apply to a holder of a pharmacy licence issued in respect of an approved retail pharmacy in relation to the administration of an influenza vaccine at the approved retail pharmacy.

Section 31(1) of the Act does not apply to —

a holder of a pharmacy licence who advertises, or causes to be advertised, any information relating to the administration of an influenza vaccine at the approved retail pharmacy to which the pharmacy licence relates; and

a person who, acting on the authority of a holder of a pharmacy licence, advertises or causes to be advertised, any information relating to the administration of an influenza vaccine at the approved retail pharmacy to which the pharmacy licence relates.